SNSE: Bathi resik saben saham (EPS TTM) Sensei Bio

The development of the Immuno-Phage platform by Sensei Biotherapeutics (SNSE) is independent of economic cycles, as demonstrated by the trailing 12-month net income per share. The level of -18.97 represents the current value of this metric. Fundamentally, the business relies on capital raising due to a lack of sales and the risks of clinical antibody test failures, leaving the company dependent on new equity offerings.

SNSE Bathi resik saben saham sajrone 12 wulan pungkasan Sensei Biotherapeutics (04.07.2022 - 16.06.2026)

Ringkesan rincian data analitis Sensei Biotherapeutics Inc (SNSE)

- rega saham lan prakiraan rega para ahli:

Kutipan saham Sensei Bio|SNSE - Konsensus nilai wajar

- informasi kapitalisasi pasar:

Kapitalisasi pasar Sensei Biotherapeutics, Inc.|SNSE - Rega Tumbas Perusahaan

- rincian valuasi buku bisnis:

Aset Bersih saben Siji Saham Sensei Biotherapeutics|SNSE - Aset Bersih Perusahaan|Rasio Nilai Pasar marang Nilai Buku senseibio.com|SNSE - Gunggung Aset Perusahaan

- indikator beban kredit lan likuiditas emiten:

Rasio Total Utang marang Ekuitas Sensei Biotherapeutics|SNSE - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Sensei Bio|SNSE - Utang agregat perusahaan|Rasio utang marang kapitalisasi buku Sensei Biotherapeutics, Inc.|SNSE - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Sensei Biotherapeutics|Indikator likuiditas cepet senseibio.com

- data bathi lan kelipatan valuasi:

SNSE - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep Sensei Biotherapeutics|SNSE - Nilai perusahaan marang bathi resik|Pangali Forward P/E Sensei Bio|SNSE - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Sensei Biotherapeutics, Inc.|SNSE - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Sensei Biotherapeutics|SNSE - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan senseibio.com|SNSE - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Sensei Biotherapeutics

- rincian pendapatan lan dodolan:

SNSE - Total pendapatan perusahaan|Prakiraan pendapatan perusahaan Sensei Bio|SNSE - Koefisien rega marang pendapatan|Multiplikator Forward P/S Sensei Biotherapeutics, Inc.

Pambiji fundamental:SNSE - senseibio.com

Sensei Biotherapeutics (SNSE) operates as a small-cap biotech with minimal environmental impact, focusing on laboratory research. The specific nature of the clinical trial stage results in a lack of large-scale revenues, which directly impacts the calculation of net income distributed per share. This trailing twelve-month (TTM) metric measures the final business efficiency, adjusted for the volume of issuance. By analyzing the TTM earnings per share (EPS), an investor assesses the financial stability of Sensei Biotherapeutics (SNSE) during periods of market volatility. The TTM EPS trend allows for the identification of the model's adaptability to development costs.

Pesaing utama